AngioDynamics, Inc.
ANGO · NASDAQ
8/31/2025 | 5/31/2025 | 2/28/2025 | 11/30/2024 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -5.5% | 11.3% | -1.2% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 55.3% | 52.7% | 54% | 54.8% |
| EBITDA | -$0 | $0 | -$0 | $0 |
| % Margin | -6.4% | 2.7% | -0.5% | 2.5% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -14.4% | -7.5% | -6.1% | -14.7% |
| EPS Diluted | -0.26 | -0.15 | -0.11 | -0.26 |
| % Growth | -73.3% | -36.4% | 57.7% | – |
| Operating Cash Flow | -$0 | $0 | -$0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | $0 | -$0 | $0 |